Expert Reaction

EXPERT REACTION: Pregnant or breastfeeding women have similar reactions to COVID-19 jabs as everyone else

Publicly released:
International
CC-0
CC-0

Comparing reactions to COVID-19 vaccines in 7,809 pregnant women, 6,815 lactating women, and 2,901 women who were neither pregnant nor lactating but were planning pregnancy, US scientists say reactions one day after the jabs were similar across the groups, and all the groups reported increased reactions following dose two of the mRNA vaccines (Moderna and Pfizer). Although the study was limited by covering only the first wave of vaccination, and relied on self-reporting of reactions, which can be unreliable, the results are comparable with previously reported findings among pregnant women, the researchers say.

Media release

From: JAMA

Short-term Reactions to COVID-19 Vaccine Among Pregnant, Lactating Individuals

What The Study Did: Researchers investigated short-term reactions associated with COVID-19 vaccines among pregnant and lactating individuals compared with individuals neither pregnant nor lactating but planning pregnancy.

Expert Reaction

These comments have been collated by the Science Media Centre to provide a variety of expert perspectives on this issue. Feel free to use these quotes in your stories. Views expressed are the personal opinions of the experts named. They do not represent the views of the SMC or any other organisation unless specifically stated.

Associate Professor Alex Polyakov is a Clinical Associate Professor in the Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne and is a Medical Director at Genea Fertility Melbourne

The study published in the JAMA Network Open examined short-term side-effects of Pfizer and Moderna COVID-19 vaccination on pregnant and breast-feeding individuals, and compared it to experiences of non-pregnant women.

This was an online based study which enrolled participants via social networks and all data collected was self-reported by the participants. More than 17,000 individuals participated in this survey, 7,809 were pregnant, 6,815 were breastfeeding and 2,901 were neither. The group were similar in terms of baseline characteristics.

The main finding was that there were no differences between the rate of minor side-effects between pregnant, breastfeeding and non-pregnant/not breastfeeding individuals. The side-effects most commonly experienced were pain at injection site (91.4%) and fatigue (31.3), with myalgia (muscle pain), headaches, chills and fever being less common. All these side-effects were observed more commonly after the second dose of the vaccine compared to the first.

The conclusions that can be drawn from this study are that minor side-effects following administration of mRNA COVID-19 vaccines are common, with pain at the injection site and fatigue being most likely to be experienced.

There is no increased risk of these side-effects for pregnant and breastfeeding individuals.

Current guidelines in Australia recommend vaccination against COVID-19 for pregnant women at any stage of pregnancy and during breastfeeding and this study supports vaccine safety in these groups.

It must also be stressed that COVID-19 infection in pregnancy is associated with an increased risk of severe clinical symptoms which may adversely affect the health of the mother and the wellbeing of the fetus.

On the other hand, there is no evidence to suggest that vaccination either during pregnancy or breastfeeding is associated with a higher risk of either long- or short-term complications, compared to the general population. The balance of risks clearly favours vaccination in these at-risk groups.

Last updated:  17 Aug 2021 1:52pm
Contact information
Contact details are only visible to registered journalists.
Declared conflicts of interest None declared.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page The URL will go live after the embargo ends
Journal/
conference:
JAMA Network Open
Research:Paper
Organisation/s: University of Washington, USA
Funder: This projectwas supported byWomen’s Reproductive Health Research grant K12HD001264-21 through the National Institute of Child Health and Human Development, grant K23AI153390-01A1 through the National Institute of Allergy and Infectious Diseases, and grant UL1 TR002319 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health for the purposes of design and conduct of the study and collection, management, analysis, and interpretation of data. The UWInstitute of Translational Health Science provided administrative Research Electronic Data Capture support for this project and was supported by grants UL1 TR002319, KL2 TR002317, and TL1 TR002318 from NCATS.
Media Contact/s
Contact details are only visible to registered journalists.